2025-07-25 - Analysis Report
Okay, here's the analysis of Merck & Co Inc (MRK), presented as you requested:

## Report on Merck & Co Inc (MRK)

**Ticker:** MRK
**Company Name:** Merck & Co Inc
**Description:** A global pharmaceutical company focused on developing and manufacturing innovative medicines and vaccines.

### 1. Performance vs. S&P 500 (VOO)

*   **MRK Cumulative Return:** -3.80%
*   **VOO Cumulative Return:** 98.88%
*   **Absolute Divergence (Current):** -101.5
*   **Relative Divergence:** 0.6 (MRK is performing near the bottom of its historical divergence range compared to VOO.)

**Analysis:** MRK has significantly underperformed the S&P 500. The large negative divergence suggests substantial relative weakness. The relative divergence near 0.6 indicates that MRK's underperformance, relative to the S&P 500, is near its historical worst levels.

#### Alpha, Beta Analysis:

| Year       | CAGR     | MDD    | Alpha   | Beta  | Cap(B) |
|------------|----------|--------|---------|-------|--------|
| 2015-2017  | 5.0%     | 58.2%  | -24.0%  | -0.0  | 134.8  |
| 2016-2018  | 43.0%    | 66.4%  | 25.0%   | -0.1  | 183.1  |
| 2017-2019  | 40.0%    | 66.4%  | 11.0%   | 0.3   | 217.9  |
| 2018-2020  | 20.0%    | 66.4%  | 0.0%    | 0.3   | 196.0  |
| 2019-2021  | -1.0%    | 65.6%  | -50.0%  | 0.3   | 192.4  |
| 2020-2022  | 13.0%    | 69.5%  | 11.0%   | 0.3   | 278.6  |
| 2021-2023  | 31.0%    | 69.5%  | 13.0%   | 0.3   | 273.8  |
| 2022-2024  | -7.0%    | 69.5%  | -33.0%  | 0.2   | 249.8  |
| 2023-2025  | -56.0%   | 61.4%  | -106.0% | 0.5   | 211.2  |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate shows significant volatility, with recent years showing substantial declines.
*   **MDD:**  High Maximum Drawdowns suggest substantial risk and volatility in MRK's returns.
*   **Alpha:** Negative Alpha values in several periods indicate underperformance relative to the market risk-adjusted benchmark.
*   **Beta:** Beta values generally close to zero suggest a relatively low correlation with the overall market. However, more recent Beta values are slightly higher, indicating a potentially increasing correlation.
*   **Cap(B):** Market capitalization has fluctuated, with a notable decrease in the most recent period.

### 2. Recent Price Action

*   **Current Price:** 84.11
*   **Last Market Data:** Price: 84.11, Previous Close: 83.98, Change: 0.15
*   **5-Day Moving Average:** 81.794
*   **20-Day Moving Average:** 81.6594
*   **60-Day Moving Average:** 79.8445

**Analysis:** The price is above all three moving averages, indicating a short-term upward trend. The small change from the previous close suggests only minor price movement recently.

### 3. Technical Indicators and Expected Return

*   **Market Risk Indicator (MRI):** 0.3274 (Low Risk)
*   **RSI:** 60.53 (Approaching overbought territory)
*   **PPO:** 0.08 (Positive, indicating upward momentum)
*   **Hybrid Signal:** cash_7%_Buy 90% of cash (904 shares - Safe - MRI:0.33)
*   **20-Day Relative Divergence Change:** -1.3 (Indicates recent underperformance compared to VOO)
*   **Expected Return:** -1129.2% (Significant underperformance expected vs. S&P 500 over a 2+ year period)

**Analysis:** The MRI suggests low market risk. The RSI is approaching overbought levels, suggesting the recent upward move might be limited. The negative relative divergence change confirms recent underperformance.  The extremely negative expected return is a major concern.  The Hybrid Signal suggests a conservative "Buy" recommendation with a high cash reserve, likely reflecting the uncertainty.

### 4. Recent News & Significant Events

*   **2025-07-21:** Major business developments, regulatory changes, or market events.
*   **2025-07-25:** Analysts discussing performance and outlook in the context of industry trends and global economic factors.
*   **2025-07-24:** Notable stock volatility due to recent news, earnings reports, or executive actions.
*   **2025-07-22:** Market experts highlight risks and opportunities, advising investors to monitor news.

**Analysis:** The news highlights potential catalysts for volatility and suggests that MRK is currently under scrutiny due to significant events.

### 5. Recent Earnings Analysis

| 날짜       | EPS  | 매출      |
|------------|------|-----------|
| 2025-05-02 | 2.01 | 15.53 B$  |
| 2024-11-06 | 1.25 | 16.66 B$  |
| 2024-08-05 | 2.15 | 16.11 B$  |
| 2024-05-03 | 1.88 | 15.78 B$  |
| 2025-05-02 | 1.88 | 15.78 B$  |

**Analysis:** Revenue has been fluctuating. Earnings per share (EPS) shows some variation, with the most recent EPS aligning with the EPS a year prior. More consistent revenue would be desirable.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue   | Profit Margin |
|------------|-----------|---------------|
| 2025-03-31 | $15.53B   | 77.98%        |
| 2024-12-31 | $15.62B   | 75.50%        |
| 2024-09-30 | $16.66B   | 75.51%        |
| 2024-06-30 | $16.11B   | 76.76%        |
| 2024-03-31 | $15.78B   | 77.56%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE     |
|------------|-----------|---------|
| 2025-03-31 | $48.34B   | 10.51%  |
| 2024-12-31 | $46.31B   | 8.08%   |
| 2024-09-30 | $44.50B   | 7.09%   |
| 2024-06-30 | $43.58B   | 12.52%  |
| 2024-03-31 | $40.36B   | 11.80%  |

**Analysis:**  Revenue has shown slight fluctuations, while profit margins have remained consistently high, indicating strong profitability.  Equity has been steadily increasing, which is a positive sign. Return on Equity (ROE) has fluctuated, showing variability in the company's profitability relative to its equity.

### 7. Overall Summary

Merck & Co Inc (MRK) is currently showing mixed signals. While the recent price action is positive, driven by a possible short-term upward trend, it has significantly underperformed the S&P 500. High Maximum Drawdowns suggest substantial risk and volatility in MRK's returns. The expected return is alarmingly negative, suggesting significant potential for underperformance versus the market. Recent news indicates volatility and potential major events affecting the company. Although revenue and earnings have been somewhat inconsistent, the profit margins are relatively high. Overall, a cautious approach is warranted, considering the high volatility and underperformance.

